Frontlight ResearchEarly access
Endometrial cancer trials in United States
199 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleEvaluation of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Endometrial Cancer
- Where
- New Haven
- Age
- 18 years to 100 years
- People
- 50
- Run by
- Alessandro Santin
See details and how to joinNCT03832361 - Early phase 1Taking peopleA Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 28
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05691010 - Phase 2Taking peopleRESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
- Where
- Boston
- Age
- 18 years and over
- People
- 110
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT03675893 - No phaseEnrolling by invitationThe Use of a Novel Vaginal Speculum for Endometrial Biopsies
- Where
- Englewood
- Age
- 18 years to 90 years
- People
- 100
- Run by
- Rocky Vista University, LLC
See details and how to joinNCT07217353 - No phaseNot yet taking people in United StatesSignatera Assessment in Early-Stage Endometrial Cancer
- Where
- Birmingham, Charlotte, Chicago, Cleveland, Columbus, Durham, La Jolla, Los Angeles, Miami, Minneapolis, New York, Pittsburgh
- Age
- 18 years and over
- People
- 1,010
- Run by
- Natera, Inc.
See details and how to joinNCT07339384 - No phaseTaking peopleNon-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
- Where
- Jacksonville, Rochester, Scottsdale
- Age
- 55 years and over
- People
- 300
- Run by
- Mayo Clinic
See details and how to joinNCT06365905 - No phaseTaking peopleMenstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
- Where
- Boston
- Age
- 18 years and over
- People
- 25
- Run by
- Jessica D. St. Laurent, MD
See details and how to joinNCT07220239 - Phase 2Not yet taking people in United StatesElacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 50
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT07634601 - Phase 1Taking peoplePhase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 21
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05819892 - Phase 1/2Taking peopleA Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Where
- Atlanta, Augusta, Baltimore, Camden, Charleston, Charlottesville, Chattanooga, Chicago, Cincinnati, Coral Gables, Detroit, Hilliard, Houston, Little Rock, Louisville, Nashville, New York, Palo Alto, Portland, Skokie, Tampa, Tucson
- Age
- 18 years and over
- People
- 182 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT04300556 · EU 2023-506868-14-00 - Phase 2Taking peopleA Study of Lorigerlimab in Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Houston, Los Angeles, Madison, New Orleans, Pittsburgh, San Antonio
- Age
- 18 years and over
- People
- 80 worldwide
- Run by
- MacroGenics
See details and how to joinNCT06730347 - No phaseTaking peopleLynch Syndrome X-Talk of Enteral Mucosa With Immune System
- Where
- Monrovia
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- San Raffaele University
See details and how to joinNCT06708429 - Phase 3Taking peopleVaginal Cuff Brachytherapy Fractionation Study
- Where
- Baltimore, Charlottesville, Syracuse
- Age
- 18 years and over
- People
- 258
- Run by
- Kara Romano, MD
See details and how to joinNCT03785288 - Phase 1/2Taking peopleCabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
- Where
- Birmingham
- Age
- 18 years and over
- People
- 37
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT05559879 - Phase 1/2Taking peopleA Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
- Where
- Boston, Buffalo, Chicago, Duarte, Durham, Englewood, Memphis, Miami Beach, Minneapolis, Morristown, New York, Oklahoma City, Omaha, Pittsburgh, Portland, Providence, San Francisco, Scarborough, St Louis, Washington D.C., Westwood
- Age
- 18 years and over
- People
- 148
- Run by
- Alliance Foundation Trials, LLC.
See details and how to joinNCT04486352 - Phase 1/2Taking peopleA Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Where
- Boston, Chicago, Columbus, Fairfax, Houston, Jacksonville, New Haven, New York, Philadelphia, Phoenix, Rochester, Salt Lake City, Seattle
- Age
- 18 years and over
- People
- 120
- Run by
- 858 Therapeutics, Inc.
See details and how to joinNCT06395519 - No phaseTaking peopleImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
- Where
- Jacksonville, Phoenix, Rochester
- Age
- 18 years and over
- People
- 324
- Run by
- Mayo Clinic
See details and how to joinNCT06349642 - Phase 1Taking peopleTalazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
- Where
- Baltimore, Houston
- Age
- 18 years and over
- People
- 24
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03968406 - No phaseTaking peopleExercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT04997096 - No phaseTaking peopleOutcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study
- Where
- Houston, New York, Rochester
- People
- 212 worldwide
- Run by
- Mayo Clinic
See details and how to joinNCT06689956 - No phaseTaking peopleScreening and Staging of Benign vs Malignant Pelvic Abnormalities
- Where
- Rochester
- Age
- 18 years and over
- People
- 60
- Run by
- Mayo Clinic
See details and how to joinNCT07407959 - Phase 1Taking peopleFirst in Human Study of TORL-1-23 in Participants With Advanced Cancer
- Where
- Cleveland, Fairfax, Fullerton, Lexington, Los Angeles, Minneapolis, New York, Rochester, Tyler
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- TORL Biotherapeutics, LLC
See details and how to joinNCT05103683 - Phase 1Taking peopleONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 58
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT05542407 - Phase 2Taking peopleUterine Preservation Via Lifestyle Transformation
- Where
- Albuquerque, Oklahoma City, St Louis
- Age
- 18 years and over
- People
- 96
- Run by
- Washington University School of Medicine
See details and how to joinNCT05903131 - Phase 1Taking peopleA Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Where
- Austin, Dallas, Denver, Fairfax, Greenville, Huntersville, Oklahoma City, Orlando, San Antonio, Sarasota
- Age
- 18 years and over
- People
- 96
- Run by
- Dren Bio
See details and how to joinNCT06999187